{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-002126","form_type":"8-K","ticker":"SCNX","cik":"0001382574","company_name":"Scienture Holdings, Inc.","filed_at":"2023-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.698971+00:00","generated_at":"2026-06-20T11:36:54.545564+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"TRxADE HEALTH agrees to sell Alliance Pharma and CSP to Wood Sage for up to $491k","bullets":["Sell 100% of Alliance Pharma Solutions for $125,000 and Community Specialty Pharmacy for $100,000, plus ~$266,000 under Master Service Agreement.","Closing expected April 30, 2023, subject to Wood Sage obtaining sufficient financing.","Divestiture of unprofitable B2C operations; company to focus on B2B marketplace.","Sale follows evaluation of strategic alternatives begun in Q3 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-002126","json":"https://secwatch.observer/filing/0001493152-23-002126.json","markdown":"https://secwatch.observer/filing/0001493152-23-002126.md","text":"https://secwatch.observer/filing/0001493152-23-002126.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223002126/0001493152-23-002126-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223002126/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T11:36:54.545564+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dd1fe27172b02d88f9ddb74585b3fcbf7a893297","claim":"Scienture Holdings, Inc. entered into Membership Interest Purchase Agreements (Alliance Sale Agreement and CSP Sale Agreement) with Wood Sage, LLC valued at Total consideration of $125,000 (Alliance) + $100,000 (CSP) + approximately $266,000 due under Maste (effective 2023-01-20).","evidence_excerpt":"On January 20, 2023, TRxADE HEALTH, Inc. (the “ Company ”, “ we ”, or “ us ”), entered into: (1) a Membership Interest Purchase Agreement with Wood Sage, LLC (“ Wood Sage ”), and the Company’s wholly-owned subsidiary, Alliance Pharma Solutions, LLC (“ Alliance ” and the “ Alliance Sale Agreement ”); and (2) a Membership Interest Purchase Agreement with Wood Sage and the Company’s wholly-owned subsidiary, Community Specialty Pharmacy, LLC (“ CSP ” and the “ CSP Sale Agreement ”, and together with the Alliance Sale Agreement, the “ Sale Agreements ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223002126/0001493152-23-002126-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Wood Sage, LLC"},{"label":"Value","value":"Total consideration of $125,000 (Alliance) + $100,000 (CSP) + approximately $266,000 due under Maste"},{"label":"Effective","value":"2023-01-20"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}